Synthesis, antiproliferative and antiplasmodial evaluation of new chloroquine and mefloquine-based harmiquins

1 World Health Organization, World malaria report, December 2022; https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2022; last access date March 30, 2023. Search in Google Scholar

2 World Health Organization, Cancer, February 2022; https://www.who.int/news-room/fact-sheets/detail/cancer; last access date March 30, 2023. Search in Google Scholar

3 N. Vasan, J. Baselga and D. M. Hyman, A view on drug resistance in cancer, Nature 575(7782) (2019) 299–309; https://doi.org/10.1038/s41586-019-1730-1 Search in Google Scholar

4 Y. Le Govic, S. Houzé and N. Papon, Repurposing anticancer drugs to tackle malaria, ChemMed-Chem 16(14) (2021) 2192–2194; https://doi.org/10.1002/cmdc.202100176 Search in Google Scholar

5 T. Ellis, E. Eze and B. T. Raimi-Abraham, Malaria and cancer: a critical review on the established associations and new perspectives, Infect. Agent Cancer 16(33) (2021) (14 pages); https://doi.org/10.1186/s13027-021-00370-7 Search in Google Scholar

6 C. Verbaanderd, H. Maes, M. B. Schaaf, V. P. Sukhatme, P. Pantziarka, V. Sukhatme, P. Agostinis and G. Bouche, Repurposing drugs in oncology (ReDO) – chloroquine and hydroxychloroquine as anti-cancer agents, Ecancermedicalscience 23(11) (2017) Article ID 781 (35 pages); https://doi.org/10.3332/ecancer.2017.781 Search in Google Scholar

7 H. Monma, Y. Iida, T. Moritani, T. Okimoto, R. Tanino, Y. Tajima and H. Mamoru, Chloroquine augments TRAIL-induced apoptosis and induces G2/M phase arrest in human pancreatic cancer cells, PLoS One 13(3) (2018) e0193990 (16 pages); https://doi.org/10.1371/journal.pone.0193990 Search in Google Scholar

8 R. Cao, W. Fan, L. Guo, Q. Ma, G. Zhang, J. Li, X. Chen, Z. Ren and L. Qiu, Synthesis and structure-activity relationships of harmine derivatives as potential antitumor agents, Eur. J. Med. Chem. 60 (2013) 135–143; https://doi.org/10.1016/j.ejmech.2012.11.045 Search in Google Scholar

9 G. D. Kim, Harmine hydrochloride triggers G2/M cell cycle arrest and apoptosis in HCT116 cells through ERK and PI3K/AKT/mTOR signaling pathways, Prev. Nutr. Food Sci. 26(4) (2021) 445–452; https://doi.org/10.3746/pnf.2021.26.4.445 Search in Google Scholar

10 N. S. R. S. Mota, M. R. Kviecinski, K. B. Felipe, V. M. A. S. Grinevicius, T. Siminski, G. M. Almeida, R. C. Zeferino, C. T. Pich, D. W. Filho and R. C. Pedrosa, β-carboline alkaloid harmine induces DNA damage and triggers apoptosis by a mitochondrial pathway: study in silico, in vitro and in vivo, Int. J. Funct. Nutr. 1(1) (2023) (12 pages); https://doi.org/10.3892/ijfn.2020.1 Search in Google Scholar

11 D. Shahinas, G. MacMullin, C. Benedict, I. Crandall and D. R. Pillai, Harmine is a potent antimalarial targeting Hsp90 and synergizes with chloroquine and artemisinin, Antimicrob. Agents Chemother. 56(8) (2012) 4207–4213; https://doi.org/10.1128/AAC.00328-12 Search in Google Scholar

12 S. Kumar, A. Singh, K. Kumar and V. Kumar, Recent insights into synthetic β-carbolines with anti-cancer activities, Eur. J. Med. Chem. 142 (2017) 48–73; https://doi.org/10.1016/j.ejmech.2017.05.059 Search in Google Scholar

13 D. Jiangkun, D. Wenjia, S. Uwe and W. Junru, β-Carboline alkaloid monomers and dimers: occurrence, structural diversity, and biological activities, Eur. J. Med. Chem. 157 (2018) 622–656; https://doi.org/10.1016/j.ejmech.2018.08.027 Search in Google Scholar

14 S. Aaghaz, K. Sharma, R. Jain and A. Kamal, β-Carbolines as potential anticancer agents, Eur. J. Med. Chem. 216 (2021) Article ID 113321 (25 pages); https://doi.org/10.1016/j.ejmech.2021.113321 Search in Google Scholar

15 B. Luo and X. Song, A comprehensive overview of β-carbolines and its derivatives as anticancer agents, Eur. J. Med. Chem. 224 (2021) Article ID 113688 (42 pages); https://doi.org/10.1016/j.ejmech.2021.113688 Search in Google Scholar

16 J. P. Soni, Y. Yeole and N. Shankaraiah, β-Carboline-based molecular hybrids as anticancer agents: a brief sketch, RSC Med. Chem. 12(5) (2021) 730–750; https://doi.org/10.1039/d0md00422g Search in Google Scholar

17 A. Kamboj, B. Sihag, D. S. Brar, A. Kaur and D. B. Salunke, Structure activity relationship in β-carboline derived anti-malarial agents, Eur. J. Med. Chem. 221 (2021) Article ID 113536 (15 pages); https://doi.org/10.1016/j.ejmech.2021.113536 Search in Google Scholar

18 P. Kushwaha, V. Kumar and B. Saha, Current development of β-carboline derived potential anti-malarial scaffolds, Eur. J. Med. Chem. 252 (2023) Article ID 115247 (15 pages); https://doi.org/10.1016/j.ejmech.2023.115247 Search in Google Scholar

19 Q. Zhao and G. Huang, Anticancer Hybrids, in Design of Hybrid Molecules for Drug Development (Ed. M. Decker), 1^st ed., Elsevier, Amsterdam 2017, pp. 193–218. Search in Google Scholar

20 G. Poje, L. Pessanha de Carvalho, J. Held, D. Moita, M. Prudêncio, I. Perković, T. Tandarić, R. Vianello and Z. Rajić, Design and synthesis of harmiquins, harmine and chloroquine hybrids as potent antiplasmodial agents, Eur. J. Med. Chem. 238 (2022) Article ID 114408 (15 pages); https://doi.org/10.1016/j.ejmech.2022.114408 Search in Google Scholar

21 M. Beus, D. Fontinha, J. Held, Z. Rajić, M. Prudêncio and B. Zorc, Synthesis and antiplasmodial evaluation of novel mefloquine-based fumardiamides, Acta Pharm. 69(2) (2019) 233–248; https://doi.org/10.2478/acph-2019-0019 Search in Google Scholar

22 G. Barbosa-Lima, A. M. Moraes, A. S. Araújo, E. T. da Silva, C. S. de Freitas, Y. R. Vieira, A. Marttorelli, J. C. Neto, P. T. Bozza, M. V. N. de Souza and T. M. L. Souza, 2,8-Bis(trifluoromethyl)quino-line analogs show improved anti-Zika virus activity, compared to mefloquine, Eur. J. Med. Chem. 127 (2017) 334–340; https://doi.org/10.1016/j.ejmech.2016.12.058 Search in Google Scholar

23 M. Marinović, G. Poje, I. Perković, D. Fontinha, M. Prudêncio, J. Held, L. Pessanha de Carvalho, T. Tandarić, R. Vianello and Z. Rajić, Further investigation of harmicines as novel antiplasmodial agents: synthesis, structure-activity relationship and insight into the mechanism of action, Eur. J. Med. Chem. 224 (2021) Article ID 113687 (20 pages); https://doi.org/10.1016/j.ejmech.2021.113687 Search in Google Scholar

24 M. Marinović, I. Perković, D. Fontinha, M. Prudêncio, J. Held, L. Pessanha de Carvalho, T. Tandarić, R. Vianello, B. Zorc and Z. Rajić, Novel harmicines with improved potency against Plasmodium, Molecules 25(19) (2020) Article ID 4376 (19 pages); https://doi.org/10.3390/molecules25194376 Search in Google Scholar

25 M. Marinović, Amide-type Harmicines as Potential Antimalarial Agents, doctoral dissertation, University of Zagreb Faculty of Pharmacy and Biochemistry, Zagreb 2023, pp 104. Search in Google Scholar

26 J. Held, T. Gebru, M. Kalesse, R. Jansen, K. Gerth, R. Müller and B. Mordmüller, Antimalarial activity of the myxobacterial macrolide chlorotonil A, Antimicrob. Agents Chemother. 58(11) (2023) 6378–6384; https://doi.org/10.1128/AAC.03326-14 Search in Google Scholar

27 H. Noedl, J. Bronnert, K. Yingyuen, B. Attlmayr, H. Kollaritsch and M. Fukuda, Simple histi-dine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing, Antimicrob. Agents Chemother. 49(8) (2005) 3575–3577; https://doi.org/10.1128/AAC.49.8.3575-3577.2005 Search in Google Scholar

28 R Core Team, R: A language and environment for statistical computing version 4.1.3. R Foundation for Statistical Computing, Vienna, Austria; https://www.R-project.org/; last access December 10, 2022. Search in Google Scholar

29 T. J. Maher and D. A. Johson, Receptors and Drug Action, in Foye’s Principles of Medicinal Chemistry (Ed. T. L. Lemke, D. A. Williams, S. W. Zito, Ph. D. Roche, F. Victoria), 6^th ed., Lippincott, Williams and Wilkins, Philadelphia, 2007. Search in Google Scholar

30 A. K. Ghosh and M. Brindisi, Urea derivatives in modern drug discovery and medicinal chemistry, J. Med. Chem. 63(6) (2020) 2751–2788; https://doi.org/10.1021/acs.jmedchem.9b01541 Search in Google Scholar

31 K. Pavić, M. Beus, G. Poje, L. Uzelac, M. Kralj and Z. Rajić, Synthesis and biological evaluation of harmirins, novel harmine-coumarin hybrids as potential anticancer agents, Molecules 26(21) (2021) Article ID 6490 (19 pages); https://doi.org/10.3390/molecules26216490 Search in Google Scholar